Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

KLDO

Kaleido Biosciences (KLDO)

Kaleido Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:KLDO
DateTimeSourceHeadlineSymbolCompany
05/06/20228:16AMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:KLDOKaleido Biosciences Inc
05/02/20226:20AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:KLDOKaleido Biosciences Inc
04/27/20225:03AMTipRanksAnalysts Offer Insights on Healthcare Companies: and Kaleido Biosciences (KLDO)NASDAQ:KLDOKaleido Biosciences Inc
04/25/20224:43PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KLDOKaleido Biosciences Inc
04/25/20224:41PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:KLDOKaleido Biosciences Inc
04/18/20229:25AMEdgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:KLDOKaleido Biosciences Inc
04/08/20229:26AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KLDOKaleido Biosciences Inc
04/04/20227:45AMTipRanksKaleido Biosciences (KLDO) was Downgraded to a Hold Rating at Chardan CapitalNASDAQ:KLDOKaleido Biosciences Inc
03/16/20228:30AMGlobeNewswire Inc.Radius Health Announces Leadership AppointmentsNASDAQ:KLDOKaleido Biosciences Inc
03/09/20224:26PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KLDOKaleido Biosciences Inc
03/02/20224:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
03/02/20224:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
02/28/20229:00AMPR Newswire (US)Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory AffairsNASDAQ:KLDOKaleido Biosciences Inc
02/15/202210:05AMPR Newswire (US)INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANTNASDAQ:KLDOKaleido Biosciences Inc
02/09/20229:25AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:KLDOKaleido Biosciences Inc
01/28/20224:44PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KLDOKaleido Biosciences Inc
01/21/202211:04AMGlobeNewswire Inc.Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohn’s and Colitis CongressNASDAQ:KLDOKaleido Biosciences Inc
01/18/20225:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
01/18/20225:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
01/18/20225:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
01/18/20225:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
12/16/20215:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KLDOKaleido Biosciences Inc
12/16/20215:17PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:KLDOKaleido Biosciences Inc
12/06/20217:30AMGlobeNewswire Inc.Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT™) to Prevent Childhood-Onset of Atopic, Immune and Metabolic ConditionsNASDAQ:KLDOKaleido Biosciences Inc
11/15/20217:30AMGlobeNewswire Inc.Kaleido Biosciences to Participate in the Piper Sandler 33rd Annual Virtual Healthcare ConferenceNASDAQ:KLDOKaleido Biosciences Inc
11/10/20217:30AMGlobeNewswire Inc.Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical OfficerNASDAQ:KLDOKaleido Biosciences Inc
11/01/20217:30AMGlobeNewswire Inc.Kaleido Biosciences Reports Third Quarter 2021 Financial ResultsNASDAQ:KLDOKaleido Biosciences Inc
10/13/202110:11AMPR Newswire (US)Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate ChangeNASDAQ:KLDOKaleido Biosciences Inc
10/12/20217:30AMGlobeNewswire Inc.Kaleido Biosciences to Participate in the Jefferies Virtual Next Generation IBD Therapeutics SummitNASDAQ:KLDOKaleido Biosciences Inc
10/05/20217:00AMGlobeNewswire Inc.Kaleido Biosciences Announces New Clinical and Preclinical Data Supporting Advancement of KB295 to a Phase 2 Clinical Study in Mild-to-Moderate Ulcerative ColitisNASDAQ:KLDOKaleido Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:KLDO